FindTrial
Sign In

The safety and efficacy of intravenous infusion of lidocaine in the treatment of neuropathological pain: a retrospective study

The safety and efficacy of intravenous infusion of lidocaine in the treatment of neuropathological pain: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097754
Enrollment
Unknown
Registered
2025-02-25
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathological pain

Interventions

Patients who receive intravenous infusion of lidocaine to treat neuropathological pain:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study subjects were patients who suffered from neuropathological pain and received at least one intravenous infusion of ridocaine at West China Hospital of Sichuan University from September 2019 to September 2024.

Exclusion criteria

Exclusion criteria: Allergic to lidocaine or other local anesthetics.

Design outcomes

Primary

MeasureTime frame
The occurrence of adverse reactions after treatment;VAS Score;—

Countries

China

Contacts

Public ContactXiao Hong

West China Hospital of Sichuan University

xiaohonghuaxi@126.com+86 189 8060 1980

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026